Dirk plugs Benitec!, page-44

Agree with you, Jemma, but notice the "if" in my post. But that "if" is predicated on positive news so far, quite extensive preclinical work, and the knowledge that hep b becomes easier "if" TT-034 works. Additionally, every IPO I've been involved in or watching has always gone up. Galapagos, Spark, even Axovant, which I chose not to participate in, still peaked like crazy at midday and even ended in the black despite its serious observations and reservations. Some of us just feel as though we should be able to read between the lines a little more. Just my opinion though.